Publications by authors named "Clementine Carlet"
Background: Late-onset adverse events (AEs) of anti-programmed cell death 1 (anti-PD1) antibodies have not been systematically described.
Objectives: The purpose was to evaluate late-onset AEs in melanoma patients treated with anti-PD1 administered for at least 2 years in a real-life setting.
Methods: Patients were screened from MelBase, a French multicentric biobank dedicated to the prospective follow up of unresectable stage III or IV melanoma.
Dissecting cellulitis of the scalp treated by tumour necrosis factor inhibitors: a case series.
Eur J Dermatol
February 2021
Article Synopsis
- Dissecting cellulitis of the scalp (DCS) is a rare and hard-to-treat inflammatory condition affecting the scalp, which is often resistant to standard therapies.
- A study involving nine patients who had DCS and were treated with TNF inhibitors showed promising results, with significant reductions in symptoms and improvements in quality of life.
- The findings suggest that TNF inhibitors can be effective in managing DCS for patients who do not respond to conventional treatments.
Background: Although infliximab (IFX) has been available since 2005, there are very little data on the long-term drug survival of infliximab in real-life.
Objective: Our aim was to identify and describe psoriasis patients treated with IFX for longer than 6 years.
Methods: Psoriasis patients treated with IFX for longer than 6 years were retrospectively included.
Postoperative purpuric contact dermatitis: Think about antiseptics.
Contact Dermatitis
September 2019